Best deals to access real time data! |
|
SMALL CAP BASIC
Monthly Subscription
for only
|
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last: $ 44.20 ▼ -0.17 (-0.38%) | |
| Company Name | Stock Ticker Symbol | Market | Type | ISIN | Company Description |
|---|---|---|---|---|---|
| Pfizer, Inc. | PFE | NYSE | Ordinary Share |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| -0.13 | -0.29% | 44.37 | 44.51 | 44.02 | 44.44 | 44.5 | 17:50:25 |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 74,129 | 17,103,310 | $ 44.3128 | $ 757.9M | 17.33M | 33.20 - 45.81 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:53:39 | nxtday | 251,776 | $44.37 | USD |
| Industry Sector |
|---|
| Drug Manufacturers - Major |
Pfizer, Inc. Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 260.1B | 5.86B | $ 21.31B | 3.57 | 12.30 | 5.95B |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 1.36 | 3.07% | 11/08/2018 | -598.72k | 76.00% |
Pfizer, Inc. News
Pfizer Presents Overall Survival Data From PALOMA-3 Trial of IBRANCE® (palbociclib) in Patients With HR+, HER2- Metastatic B... Business Wire • Sat Oct 20, 2018 10:30 AM (2 days ago)
Pain Treatment Developer Centrexion Reveals IPO Plans Dow Jones News • Fri Oct 19, 2018 7:03 PM (3 days ago)
Combo of Merck's Keytruda, Pfizer's Inlyta Meets Primary Endpoints Dow Jones News • Thu Oct 18, 2018 8:35 AM (4 days ago)
Health Care Up On Stronger Earnings -- Health Care Roundup Dow Jones News • Wed Oct 17, 2018 4:36 PM (5 days ago)
Pfizer Looks to Reduce Headcount by 2%--Reports Dow Jones News • Wed Oct 17, 2018 2:47 PM (5 days ago)
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) • Tue Oct 16, 2018 6:45 PM (6 days ago)
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) • Tue Oct 16, 2018 6:45 PM (6 days ago)
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PFE Price Data
| Period † | Open | High | Low | VWAP | Min Vol | Max Vol | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|---|---|
| 1 Week | 43.65 | 44.83 | 42.98 | 43.9768 | 15M | 21M | 18M | 0.72 | 1.65% |
| 1 Month | 43.94 | 45.81 | 42.4038 | 44.1347 | 11M | 38M | 18M | 0.43 | 0.98% |
| 3 Months | 38.36 | 45.81 | 38.14 | 42.4810 | 11M | 42M | 18M | 6.01 | 15.67% |
| 6 Months | 36.67 | 45.81 | 34.37 | 39.2733 | 9M | 43M | 17M | 7.7 | 21.00% |
| 1 Year | 36.3 | 45.81 | 33.2 | 37.6688 | 6M | 49M | 18M | 8.07 | 22.23% |
| 3 Years | 34 | 45.81 | 28.25 | 34.0054 | 6M | 280M | 22M | 10.37 | 30.50% |
| 5 Years | 30.45 | 45.81 | 27.51 | 33.0295 | 1k | 280M | 23M | 13.92 | 45.71% |
Pfizer, Inc. Description
| Pfizer Inc is a research-based biopharmaceutical company. The Company has five operating segments—Primary Care; Specialty Care and Oncology; Established Products and Emerging Markets; Animal Health; and Consumer Healthcare. |
